Page last updated: 2024-08-22

angiotensin ii and withaferin a

angiotensin ii has been researched along with withaferin a in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Kakar, SS; Straughn, AR	1

Reviews

1 review(s) available for angiotensin ii and withaferin a

Article	Year
Withaferin A: a potential therapeutic agent against COVID-19 infection. Journal of ovarian research, 2020, Jul-19, Volume: 13, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Betacoronavirus; Cachexia; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Humans; Mice; Ovarian Neoplasms; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptor, Angiotensin, Type 1; RNA, Messenger; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Withanolides; Xenograft Model Antitumor Assays	2020

Article

Year

Withaferin A: a potential therapeutic agent against COVID-19 infection.

Journal of ovarian research, 2020, Jul-19, Volume: 13, Issue:1

Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Betacoronavirus; Cachexia; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Humans; Mice; Ovarian Neoplasms; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptor, Angiotensin, Type 1; RNA, Messenger; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Withanolides; Xenograft Model Antitumor Assays

2020